{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:34:46Z","timestamp":1793450086002,"version":"4.5.0"},"reference-count":304,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT","award":["PTDC\/SAU-TOX\/117481\/2010"],"award-info":[{"award-number":["PTDC\/SAU-TOX\/117481\/2010"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT","award":["PTDC\/SAU-NMC\/110990\/2009"],"award-info":[{"award-number":["PTDC\/SAU-NMC\/110990\/2009"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT","award":["PTDC\/SAU-NEU\/103325\/2008"],"award-info":[{"award-number":["PTDC\/SAU-NEU\/103325\/2008"]}]},{"name":"Portugal, Programa de Est\u00edmulo \u00e0 Investiga\u00e7\u00e3o da Faculdade de Medicina"},{"name":"Universidade de Coimbra, Portugal","award":["PMADSC\/2011"],"award-info":[{"award-number":["PMADSC\/2011"]}]},{"name":"Quadro de Refer\u00eancia Estrat\u00e9gico Nacional (QREN"},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","award":["SFRH\/BPD\/26872\/2006"],"award-info":[{"award-number":["SFRH\/BPD\/26872\/2006"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bbadis.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T18:03:09Z","timestamp":1357927389000},"page":"527-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration"],"prefix":"10.1016","volume":"1832","author":[{"given":"A.I.","family":"Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Candeias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.X.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pl\u00e1cido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.01.008_bb1535","first-page":"384017","article-title":"Insulin in central nervous system: more than just a peripheral hormone","author":"Duarte","year":"2012","journal-title":"J. Aging Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinthera.2011.04.015","article-title":"Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus","volume":"33","author":"Campbell","year":"2011","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1540","series-title":"Diabetes Atlas","first-page":"15","author":"Sicree","year":"2006"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0020","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1550","author":"World Health Organization"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0035","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2337\/db11-1186","article-title":"Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities","volume":"61","author":"Carvalho","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneur.64.4.570","article-title":"Relation of diabetes to mild cognitive impairment","volume":"64","author":"Luchsinger","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresrev.2007.09.001","article-title":"Common pathological processes in Alzheimer disease and type 2 diabetes: a review","volume":"56","author":"Li","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0050","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.neurobiolaging.2005.08.015","article-title":"The impact of diabetes on cognition: what can be learned from rodent models?","volume":"26","author":"Biessels","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2009-0972","article-title":"An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease","volume":"16","author":"Moreira","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0028-3843(14)60005-0","article-title":"The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease","volume":"44","author":"Magierski","year":"2010","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1555","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/dmrr.632","article-title":"Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT)","volume":"22","author":"Akisaki","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0075","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00125-003-1235-0","article-title":"Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI","volume":"46","author":"den Heijer","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0080","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2337\/diabetes.55.04.06.db05-1323","article-title":"Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes","volume":"55","author":"Manschot","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0085","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/diabetes.53.3.687","article-title":"Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study","volume":"53","author":"Schmidt","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0090","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nbd.2006.03.015","article-title":"Diabetes, leukoencephalopathy and rage","volume":"23","author":"Toth","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2011.12.063","article-title":"Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation","volume":"1441","author":"Correia","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbadis.2008.12.003","article-title":"(Pre)diabetes, brain aging, and cognition","volume":"1792","author":"Roriz-Filho","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2009.05.032","article-title":"Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus","volume":"1280","author":"Bruehl","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-211-73574-9_28","article-title":"Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach","volume":"72","author":"Salkovic-Petrisic","year":"2007","journal-title":"J. Neural Transm."},{"issue":"Suppl.","key":"10.1016\/j.bbadis.2013.01.008_bb1560","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.neurobiolaging.2005.08.021","article-title":"Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation","volume":"26","author":"Craft","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/13813450902949012","article-title":"Insulin and the brain","volume":"115","author":"Laron","year":"2009","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JAD-2008-13302","article-title":"An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease","volume":"13","author":"Erol","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-8993(92)90313-X","article-title":"Developmental regulation of insulin in the mammalian central nervous system","volume":"582","author":"Schechter","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1565","first-page":"304","article-title":"CNS regulation of carbohydrate metabolism","volume":"vol. 10","author":"LeRoith","year":"1983"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0140","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0149-7634(00)00040-3","article-title":"Insulin receptors and insulin action in the brain: review and clinical implications","volume":"24","author":"Schulingkamp","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0145","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/01.WNL.0000065916.25128.25","article-title":"Insulin increases CSF Abeta42 levels in normal older adults","volume":"60","author":"Watson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0150","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1055\/s-2003-40452","article-title":"Memory function and brain glucose metabolism","volume":"36","author":"Hoyer","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2004.01.044","article-title":"Biphasic effects of stress upon GLUT8 glucose transporter expression and trafficking in the diabetic rat hippocampus","volume":"1006","author":"Piroli","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0160","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/diacare.28.3.726","article-title":"The effects of type 1 diabetes on cognitive performance: a meta-analysis","volume":"28","author":"Brands","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0165","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.2337\/diabetes.54.12.3343","article-title":"Peripheral hyperinsulinemia promotes tau phosphorylation in vivo","volume":"54","author":"Freude","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0006-8993(98)00510-1","article-title":"Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment","volume":"800","author":"Biessels","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(02)02887-1","article-title":"Hippocampal neuronal apoptosis in type 1 diabetes","volume":"946","author":"Li","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0180","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/diabetes.54.5.1497","article-title":"The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats","volume":"54","author":"Sima","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0185","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/db07-0171","article-title":"Alzheimer-like changes in rat models of spontaneous diabetes","volume":"56","author":"Li","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-328X(02)00487-4","article-title":"Insulin-responsive glucose transporters\u2014GLUT8 and GLUT4 are expressed in the developing mammalian brain","volume":"107","author":"Sankar","year":"2002","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0195","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s001250051002","article-title":"Obesity, diabetes and the central nervous system","volume":"41","author":"Porte","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0200","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1471-4159.1986.tb00686.x","article-title":"Insulin is released from rat brain neuronal cells in culture","volume":"47","author":"Clarke","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0205","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/272827a0","article-title":"Insulin receptors are widely distributed in the central nervous system of the rat","volume":"272","author":"Havrankova","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.physbeh.2005.08.054","article-title":"Factors promoting and ameliorating the development of obesity","volume":"86","author":"Levin","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3148\/63.1.2002.20","article-title":"Insulin resistance: concepts, controversies, and the role of nutrition","volume":"63","author":"Sievenpiper","year":"2002","journal-title":"Can. J. Diet. Pract. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1570","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.physbeh.2006.07.003","article-title":"Metabolic sensing neurons and the control of energy homeostasis","volume":"89","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0225","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2337\/diabetes.54.5.1264","article-title":"Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans","volume":"54","author":"Porte","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0230","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.2337\/diabetes.53.10.2521","article-title":"Neuronal glucosensing: what do we know after 50years?","volume":"53","author":"Levin","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0235","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1254\/jphs.CRJ05006X","article-title":"New twist on neuronal insulin receptor signaling in health, disease, and therapeutics","volume":"99","author":"Wada","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0240","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1172\/JCI29063","article-title":"Central insulin action in energy and glucose homeostasis","volume":"116","author":"Plum","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0245","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nature03439","article-title":"Hypothalamic K(ATP) channels control hepatic glucose production","volume":"434","author":"Pocai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0250","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.2337\/db06-S009","article-title":"The inhibitory effects of insulin on hepatic glucose production are both direct and indirect","volume":"55","author":"Girard","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0255","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0166-2236(00)01656-8","article-title":"Cognition and synaptic plasticity in diabetes mellitus","volume":"23","author":"Gispen","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0260","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00125-003-1246-x","article-title":"Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats","volume":"46","author":"Carvalheira","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0265","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","article-title":"Phosphorylation of IRS proteins, insulin action, and insulin resistance","volume":"296","author":"Boura-Halfon","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature05026","article-title":"Central nervous system control of food intake and body weight","volume":"443","author":"Morton","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2004.02.052","article-title":"Cerebral glucose metabolism in diabetes mellitus","volume":"490","author":"McCall","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0280","first-page":"387","article-title":"Insulin in the brain: a hormonal regulator of energy balance","volume":"13","author":"Schwartz","year":"1992","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1575","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/endo-118-5-1835","article-title":"Oligosaccharide heterogeneity of insulin receptors. Comparison of N-linked glycosylation of insulin receptors in adipocytes and brain","volume":"118","author":"Heidenreich","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0290","doi-asserted-by":"crossref","first-page":"11672","DOI":"10.1016\/S0021-9258(20)71260-3","article-title":"Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain","volume":"259","author":"Clarke","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0295","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0149-7634(01)00016-1","article-title":"Cognitive effects of insulin in the central nervous system","volume":"25","author":"Park","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mcn.2004.08.009","article-title":"Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons","volume":"28","author":"Huang","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0305","series-title":"Research Progress in Alzheimer's Disease and Dementia","first-page":"23","article-title":"Brain function and insulin signal transduction in sporadic Alzheimer's disease","author":"Hoyer","year":"2006"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0310","doi-asserted-by":"crossref","first-page":"34893","DOI":"10.1074\/jbc.274.49.34893","article-title":"Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats","volume":"274","author":"Zhao","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)00103-6","article-title":"GLUT4 glucose transporter expression in rodent brain: effect of diabetes","volume":"797","author":"Vannucci","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0320","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0325","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.2337\/diabetes.51.12.3384","article-title":"The role of insulin in human brain glucose metabolism: an 18fluorodeoxyglucose positron emission tomography study","volume":"51","author":"Bingham","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0330","doi-asserted-by":"crossref","first-page":"11114","DOI":"10.1074\/jbc.M410894200","article-title":"Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production","volume":"280","author":"Ghosh","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0335","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1096\/fj.01-1027com","article-title":"High glucose induced oxidative stress and mitochondrial dysfunction in neurons","volume":"16","author":"Russell","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0340","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db06-0030","article-title":"Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress","volume":"55","author":"Duarte","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0345","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbamcr.2008.02.016","article-title":"Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3\u03b2 signaling pathways and changes in protein expression","volume":"1783","author":"Duarte","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1523-1755.2003.00728.x","article-title":"Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species","volume":"63","author":"Koo","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0355","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/diabetes.48.10.1915","article-title":"No effect of insulin on glucose blood\u2013brain barrier transport and cerebral metabolism in humans","volume":"48","author":"Hasselbalch","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0360","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.2337\/diabetes.50.10.2203","article-title":"The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport\/metabolism in humans","volume":"50","author":"Seaquist","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0365","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0370","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000054694","article-title":"Improving influence of insulin on cognitive functions in humans","volume":"74","author":"Kern","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0375","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/diabetes.53.8.2110","article-title":"Oxidative stress affects synaptosomal \u03b3-aminobutyric acid and glutamate transport in diabetic rats: the role of insulin","volume":"53","author":"Duarte","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(03)02679-9","article-title":"Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions","volume":"977","author":"Duarte","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0385","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2014is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0395","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","article-title":"Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease","volume":"7","author":"de la Monte","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0400","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0166-2236(03)00163-2","article-title":"Potential roles of insulin and IGF-1 in Alzheimer's disease","volume":"26","author":"Gasparini","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0405","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0410","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0415","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/hmg\/9.14.2149","article-title":"Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats","volume":"9","author":"Fakhrai-Rad","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0420","first-page":"466","article-title":"Cerebral proteolysis of amiloid-b peptide: relevance of insulin-degrading enzyme in Alzheimer's disease","volume":"69","author":"Leal","year":"2009","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0425","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0430","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signalling","volume":"21","author":"Gasparini","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0435","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0440","first-page":"373","article-title":"The relationship between Alzheimer's disease and diabetes: type 3 diabetes?","volume":"14","author":"Kroner","year":"2009","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0445","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0450","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","article-title":"Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease","volume":"9","author":"Lester-Coll","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0455","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1210\/en.2005-0063","article-title":"Tau is hyperphosphorylated in the insulin-like growth factor-I null brain","volume":"146","author":"Cheng","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0460","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1523\/JNEUROSCI.23-18-07084.2003","article-title":"Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation","volume":"23","author":"Schubert","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0465","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0470","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/jnr.21787","article-title":"Defective insulin signalling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin","volume":"86","author":"Jolivalt","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0475","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.expneurol.2009.11.005","article-title":"Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice","volume":"223","author":"Jolivalt","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0480","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0306-4522(00)00200-1","article-title":"Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons","volume":"99","author":"Lesort","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0485","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1210\/en.2009-0695","article-title":"Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes","volume":"150","author":"Kim","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0490","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0303-7207(01)00455-5","article-title":"Role of insulin and insulin receptor in learning and memory","volume":"177","author":"Zhao","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0495","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer's disease?","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0500","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2337\/diabetes.53.7.1824","article-title":"Direct insulin signalling of neurons reverses diabetic neuropathy","volume":"53","author":"Brussee","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0505","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1210\/me.2010-0163","article-title":"The inositol phosphatase SHIP2 negatively regulates insulin\/IGF-I actions implicated in neuroprotection and memory function in mouse brain","volume":"24","author":"Soeda","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0510","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pneurobio.2006.06.003","article-title":"Insulin signaling in the central nervous system: learning to survive","volume":"79","author":"van der Heide","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0515","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00109-004-0552-1","article-title":"Neurodegenetive disorders associated with diabetes mellitus","volume":"82","author":"Ristow","year":"2004","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0520","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2004.02.048","article-title":"Modulation ofmemory by insulin and glucose: neuropsychological observations in Alzheimer's disease","volume":"490","author":"Watson","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0525","doi-asserted-by":"crossref","first-page":"C641","DOI":"10.1152\/ajpcell.00222.2006","article-title":"Mitochondria and neuronal activity","volume":"292","author":"Kann","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0530","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/0148607104028005364","article-title":"The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function","volume":"28","author":"Scheepers","year":"2004","journal-title":"J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0535","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","article-title":"Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease","volume":"1792","author":"Zhao","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0540","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0545","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0550","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.3233\/JAD-2011-111127","article-title":"Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin","volume":"30","author":"Moreira","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0555","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/diabetes.52.1.165","article-title":"Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy","volume":"52","author":"Schmeichel","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0560","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2006.01.017","article-title":"Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1","volume":"23","author":"Leinninger","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0565","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00125-009-1553-y","article-title":"Diabetes regulates mitochondrial biogenesis and fission in mouse neurons","volume":"53","author":"Edwards","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0570","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0575","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2337\/diabetes.52.6.1449","article-title":"Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-\u03b2 exposure","volume":"52","author":"Moreira","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0580","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0197-4580(03)00033-2","article-title":"Cytochrome c oxidase is decreased in Alzheimer's disease platelets","volume":"25","author":"Cardoso","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2013.01.008_bb0585","doi-asserted-by":"crossref","first-page":"S535","DOI":"10.3233\/JAD-2010-100342","article-title":"Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice","volume":"20","author":"Dragicevic","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0590","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/157340606776930754","article-title":"Insulin attenuates diabetes-related mitochondrial alterations: a comparative study","volume":"2","author":"Moreira","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0595","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1677\/joe.1.06269","article-title":"Oxidative and nitrosative stress in brain mitochondria of diabetic rats","volume":"187","author":"Mastrocola","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0600","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2006.06.026","article-title":"Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics","volume":"545","author":"Butterfield","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0605","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/81649","article-title":"Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes","volume":"26","author":"Silva","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0610","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2005.07.012","article-title":"CoQ10 therapy attenuates amyloid \u03b2-peptide toxicity in brain mitochondria isolated from aged diabetic rats","volume":"196","author":"Moreira","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0615","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.nbd.2004.10.017","article-title":"Insulin protects against amyloid \u03b2-peptide toxicity in brain mitochondria of diabetic rats","volume":"18","author":"Moreira","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0620","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/157340608784872299","article-title":"Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes","volume":"4","author":"Correia","year":"2008","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0625","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/S0024-3205(00)00892-4","article-title":"Synaptosomes isolated from Goto-Kakizaki diabetic rat brain exhibit increased resistance to oxidative stress: role of vitamin E","volume":"67","author":"Santos","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0630","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1586\/eem.09.55","article-title":"Mitochondrial stress and the pathogenesis of diabetic neuropathy","volume":"5","author":"Fernyhough","year":"2010","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0635","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.arr.2010.04.007","article-title":"Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease","volume":"9","author":"Frisardi","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0640","doi-asserted-by":"crossref","first-page":"14064","DOI":"10.1074\/jbc.275.19.14064","article-title":"Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation","volume":"275","author":"Vasquez-Vivar","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0645","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(00)80052-5","article-title":"Requirement for superoxide in excitotoxic cell death","volume":"16","author":"Patel","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0650","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1196\/annals.1297.059","article-title":"Glutathione metabolism during aging and in Alzheimer disease","volume":"1019","author":"Liu","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0655","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.freeradbiomed.2008.03.012","article-title":"Brain oxidative stress in a tripletransgenic mouse model of Alzheimer disease","volume":"44","author":"Resende","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.bbadis.2013.01.008_bb0660","first-page":"S147","article-title":"Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients","volume":"89","author":"Peerapatdit","year":"2006","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0665","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2008-15110","article-title":"Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease","volume":"15","author":"Baldeiras","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0670","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0675","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0014-5793(01)02316-X","article-title":"Mitochondrial permeability transition and oxidative stress","volume":"495","author":"Kowaltowski","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0680","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1096\/fj.04-2513fje","article-title":"Short-term hyperglycemia produces oxidative damage and apoptosis in neurons","volume":"19","author":"Vincent","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0685","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2004.11.063","article-title":"The role of impaired insulin\/IGF action in primary diabetic encephalopathy","volume":"1037","author":"Li","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0690","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2174\/138955708786369546","article-title":"Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview","volume":"8","author":"Correia","year":"2008","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0695","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.2337\/diabetes.54.12.3435","article-title":"Oxidative nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited","volume":"54","author":"Obrosova","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0700","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","article-title":"Clinical review: the role of advanced glycation end products in progression and complications of Diabetes","volume":"93","author":"Goh","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0705","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10863-009-9247-1","article-title":"Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia","volume":"41","author":"Carvalho","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0710","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2004.02.006","article-title":"N- epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease","volume":"36","author":"Girones","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0715","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/092986608784246515","article-title":"Advanced glycation: implications in tissue damage and disease","volume":"15","author":"Gasser","year":"2008","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0720","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0304-3940(83)90281-1","article-title":"Effects of hypoglycemia on the transmitter pool and the metabolic pool of glutamate in rat brain","volume":"42","author":"Engelsen","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0725","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1471-4159.1988.tb01826.x","article-title":"Glucose and synaptosomal glutamate metabolism: studies with [15N]glutamate","volume":"51","author":"Erecinska","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0730","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000017326","article-title":"Comparison of lactate and glucose metabolism in cultured neocortical neurons and astrocytes using 13C-NMR spectroscopy","volume":"20","author":"Waagepetersen","year":"1998","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0735","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/syn.20863","article-title":"Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters","volume":"65","author":"Cardoso","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0740","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0745","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbabio.2008.04.031","article-title":"Tissue specificity of mitochondrial glutamate pathways and the control of metabolic homeostasis","volume":"1777","author":"Frigerio","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0750","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.regpep.2009.08.001","article-title":"Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes","volume":"160","author":"Menge","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0755","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0006-8993(00)02426-4","article-title":"The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia","volume":"872","author":"Guyot","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0760","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0006-8993(99)01700-X","article-title":"Effect of hyperglycemia on extracellular levels of amino acids and free fatty acids in the ischemic\/reperfused rat cerebral cortex","volume":"837","author":"Phillis","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0765","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1525-1373.2000.22361.x","article-title":"Topical insulin and accumulation of excitotoxic and other amino acids in ischemic rat cerebral cortex","volume":"224","author":"Guyot","year":"2000","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01486-3","article-title":"Ageing and diabetes: implications for brain function","volume":"441","author":"Biessels","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0775","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/BF02532391","article-title":"Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium","volume":"21","author":"Vilchis","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0780","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.expneurol.2007.11.009","article-title":"Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse","volume":"210","author":"Beauquis","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0785","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nn2055","article-title":"Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons","volume":"11","author":"Stranahan","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0790","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0404.2007.00928.x","article-title":"Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats","volume":"117","author":"Zhang","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0795","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2008.12.026","article-title":"Impaired neurogenesis in adult type-2 diabetic rats","volume":"3","author":"Lang","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0800","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1468-1331.2006.01500.x","article-title":"High-fat diet impairs hippocampal neurogenesis in male rats","volume":"13","author":"Lindqvist","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0805","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jnr.22565","article-title":"Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain","volume":"89","author":"Hamilton","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0810","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.neuint.2007.04.011","article-title":"Repairing brain after stroke: a review on post-ischemic neurogenesis","volume":"50","author":"Wiltrout","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0815","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jnr.21585","article-title":"Inflammation: a new candidate in modulating adult neurogenesis","volume":"86","author":"Das","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1580","article-title":"Brain inflammation and adult neurogenesis: the dual role of microglia","author":"Ekdahl","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0825","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cmet.2008.03.012","article-title":"Diabetes and cognitive decline: are steroids the missing link?","volume":"7","author":"MacLullich","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0830","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.neurobiolaging.2005.09.014","article-title":"Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging","volume":"26","author":"Messier","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0835","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1046\/j.1460-9568.1998.00381.x","article-title":"Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats","volume":"10","author":"Oitzl","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0840","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2007-0034","article-title":"Cognitive dysfunction and diabetes mellitus","volume":"29","author":"Kodl","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0845","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1124\/jpet.105.094433","article-title":"Cumulative activation of Akt and consequent inhibition of glycogen synthase kinase-3 by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons","volume":"316","author":"Johnson-Farley","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0850","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/B:MCBI.0000026067.08356.13","article-title":"Impact of hypoglycaemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage","volume":"260","author":"Singh","year":"2004","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0855","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0860","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/B:MEBR.0000043967.78763.5b","article-title":"Hypoglycemic brain damage","volume":"19","author":"Auer","year":"2004","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0865","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/glia.20440","article-title":"Hypoglycemia, brain energetics, and hypoglycemic neuronal death","volume":"55","author":"Suh","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0870","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bbadis.2010.07.001","article-title":"Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and\/or insulin-induced hypoglycemia","volume":"1802","author":"Cardoso","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0875","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-8993(01)03333-9","article-title":"Modification of glutamate binding sites in newborn brain during hypoglycemia","volume":"927","author":"McGowan","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0880","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2337\/diabetes.49.9.1543","article-title":"Effect of hypoglycemia on amino acid and protein metabolism in healthy humans","volume":"49","author":"Battezzati","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0885","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.numecd.2008.03.009","article-title":"Protein and glutamine kinetics during counter-regulatory failure in type 1 diabetes","volume":"19","author":"Battezzati","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0890","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(93)90863-I","article-title":"Membrane lipid peroxidation induces changes in aminobutyric acid transport and calcium uptake by synaptosomes","volume":"609","author":"Palmeira","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0895","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1523\/JNEUROSCI.19-21-09209.1999","article-title":"Optical imaging reveals elevated intracellular chloride in hippocampal pyramidal neurons after oxidative stress","volume":"19","author":"Sah","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0900","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1023\/A:1020941818168","article-title":"Alanine release from the adult and developing hippocampus is enhanced by ionotropic glutamate receptor agonists and cell-damaging conditions","volume":"24","author":"Saransaari","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1585","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s11357-011-9303-8","article-title":"Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease byexendin-4","volume":"34","author":"Chen","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0910","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/archinte.168.19.2088","article-title":"National trends in treatment of type 2 diabetes mellitus, 1994\u20132007","volume":"168","author":"Alexander","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0915","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0920","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP.15.6.540","article-title":"AACE\/ACE consensus statement: statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology Consensus Panel on type 2 diabetes mellitus: an algorithm for glycemic control","volume":"15","author":"Rodbard","year":"2009","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0925","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12015-008-9024-2","article-title":"Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation","volume":"4","author":"Cimini","year":"2008","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0930","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.2006.04376.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents","volume":"101","author":"Tureyen","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0935","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","article-title":"Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice","volume":"199","author":"Pedersen","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0940","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9343(00)00339-9","article-title":"Combining insulin and oral agents","volume":"108","author":"Buse","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1590","series-title":"Contemporary Diagnosis and Management of Type 2 Diabetes","first-page":"5","article-title":"Pathophysiology of type 2 diabetes: a quartet of abnormalities","author":"Hsueh","year":"2004"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0950","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/0145721708317870","article-title":"More choices than ever before: emerging therapies for type 2 diabetes","volume":"34","author":"Campbell","year":"2008","journal-title":"Diabetes Educ."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0955","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jcem-24-10-1076","article-title":"Plasma insulin response to oral and intravenous glucose administration","volume":"24","author":"Elrick","year":"1964","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0960","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0965","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00125-004-1342-6","article-title":"Incretins, insulin secretion and type 2 diabetes mellitus","volume":"47","author":"Vilsb\u00f8ll","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0970","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jcem.86.8.7750","article-title":"Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients","volume":"86","author":"Toft-Nielsen","year":"2001","journal-title":"J. Clin. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0975","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jcem.86.8.7743","article-title":"Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes","volume":"86","author":"Toft-Nielsen","year":"2001","journal-title":"J. Clin. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0980","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.298.2.194","article-title":"Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis","volume":"298","author":"Amori","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0985","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","article-title":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase-IV","volume":"136","author":"Kieffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb0990","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.beem.2007.07.005","article-title":"DPP-4 inhibitors","volume":"21","author":"Ahr\u00e9n","year":"2007","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb0995","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.1998.tb01571.x","article-title":"The structure and function of CD26 in the T-cell immune response","volume":"161","author":"Morimoto","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1000","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.2337\/dc09-S315","article-title":"Incretin-based therapies. Viewpoints on the way to consensus","volume":"32","author":"Nauck","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2337\/dc09-1499","article-title":"Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits","volume":"33","author":"Drucker","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2337\/db07-1202","article-title":"Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice","volume":"57","author":"Lamont","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1015","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2165\/11592810-000000000-00000","article-title":"Glucagon-like peptide-1 analogues for type 2 diabetes mellitus: current and emerging agents","volume":"71","author":"Gallwitz","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1025","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1185\/03007990802418851","article-title":"Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study","volume":"24","author":"DeFronzo","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1595","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(10)60590-9","article-title":"Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial","volume":"376","author":"Bergenstal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1035","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(10)60307-8","article-title":"Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycemic control with metformin: a 26-week, randomized, parallelgroup, open-label trial","volume":"375","author":"Pratley","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1471-4159.2004.02914.x","article-title":"The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem","volume":"92","author":"Alvarez","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","author":"K\u00f6rner","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1050","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/WNR.0b013e32832fbf14","article-title":"Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system","volume":"20","author":"Hamilton","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1055","doi-asserted-by":"crossref","first-page":"e32008","DOI":"10.1371\/journal.pone.0032008","article-title":"Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2008.08.012","article-title":"The incretin system and its role in type 2 diabetes mellitus","volume":"297","author":"Holst","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI115012","article-title":"Proglucagon products in plasma of non insulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine","volume":"87","author":"Orskov","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1070","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM199205143262003","article-title":"Antidiabetogenic effect of glucagon-like peptide-1 (7\u201336) amide in normal subjects and patients with diabetes mellitus","volume":"336","author":"Gutniak","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1075","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(02)07952-7","article-title":"Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study","volume":"359","author":"Zander","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1080","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/diacare.24.9.1640","article-title":"Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA), Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men","volume":"24","author":"Rask","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1085","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.metabol.2003.11.011","article-title":"Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance","volume":"53","author":"Rask","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1090","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/db07-1315","article-title":"Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients","volume":"57","author":"Muscelli","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1463-1326.2012.01648.x","article-title":"Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia","volume":"14","author":"Herzberg-Sch\u00e4fer","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1464-5491.2000.00367.x","article-title":"Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with type 2 diabetes mellitus","volume":"17","author":"Mannucci","year":"2000","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1105","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7150\/ijms.4128","article-title":"Impaired secretion of total glucagon-like peptide 1 in people with impaired fastingglucose combined impaired glucose tolerance","volume":"9","author":"Zhang","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients","volume":"50","author":"Vilsb\u00f8ll","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1507\/endocrj.K09E-269","article-title":"Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes","volume":"7","author":"Lee","year":"2010","journal-title":"Endocr. J."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1120","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2337\/db07-1124","article-title":"Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance","volume":"57","author":"Vollmer","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-010-1896-4","article-title":"Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?","volume":"54","author":"Nauck","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2010.01.134","article-title":"Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes","volume":"393","author":"Kozawa","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/meta.2000.6251","article-title":"Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats","volume":"49","author":"Rodriquez de Fonseca","year":"2000","journal-title":"Metabolism"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2013.01.008_bb1600","first-page":"S239","article-title":"Contrasting actions of sitagliptin and exenatide on food intake, body weight, glucose stimulated insulin secretion and gastric emptying in rodents (abstract no. 0576)","volume":"50","author":"Gedulin","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood\u2013brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1150","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1210\/en.2009-0915","article-title":"GLP-1(7\u201336)-amide and Exendin-4 stimulate the HPA axis in rodents and humans","volume":"151","author":"Gil-Lozano","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/db05-0996","article-title":"Exendin-4 potently decreases ghrelin levels in fasting rats","volume":"56","author":"P\u00e9rez-Tilve","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1160","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2337\/db07-1788","article-title":"Role of central nervous system glucagon-like peptide-1 receptors in enteric glucose sensing","volume":"57","author":"Knauf","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/B978-0-12-381517-0.00013-8","article-title":"The role of GLP-1 in neuronal activity and neurodegeneration","volume":"84","author":"H\u00f6lscher","year":"2010","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1185\/03007995.2010.549466","article-title":"Neuroprotective properties of GLP-1: theoretical and practical applications","volume":"27","author":"Holst","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2010.10.008","article-title":"The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test","volume":"650","author":"Isacson","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1180","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbr.2009.06.035","article-title":"Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease","volume":"205","author":"Abbas","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.ijo.0802206","article-title":"Entry of exendin-4 into brain is rapid but may be limited at high doses","volume":"27","author":"Kastin","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1195","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.103.063222","article-title":"Brain uptake of the glucagon-like peptide-1 antagonist exendin(9\u201339) after intranasal administration","volume":"309","author":"Banks","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1200","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/jpet.300.3.958","article-title":"A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells","volume":"300","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1205","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1210","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1471-4159.2010.06731.x","article-title":"Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells","volume":"113","author":"Li","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","article-title":"Glucagon-like peptide-1 inhibits LPS-induced IL-1\u03b2 production in cultured rat astrocytes","volume":"55","author":"Iwai","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1220","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/JOE-09-0132","article-title":"Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease","volume":"202","author":"Kim","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1225","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-010-1831-8","article-title":"A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells","volume":"53","author":"Hattori","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1567205054367892","article-title":"Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease","volume":"2","author":"Perry","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1235","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nut.2009.07.008","article-title":"Exenatide and weight loss","volume":"26","author":"Bradley","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11154-011-9170-8","article-title":"Is the GLP-1 system a viable therapeutic target for weight reduction?","volume":"12","author":"Tong","year":"2011","journal-title":"Rev. Endocrinol. Metab. Disord."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1250","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1210\/en.2012-1149","article-title":"Extending the reach of exendin-4: new pathways in the control of body weight and glucose homeostasis","volume":"153","author":"Good","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1172\/JCI30227","article-title":"Gastrointestinal regulation of food intake","volume":"117","author":"Cummings","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1260","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2011-1795","article-title":"Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding associated neuropeptides in hypothalamic neurons in vivo and in vitro","volume":"153","author":"Dalvi","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1265","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/ajcn\/84.3.556","article-title":"Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans","volume":"84","author":"Pannacciulli","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2362.1997.540613.x","article-title":"Effects of glucagon-like peptide 1 (7\u201336 amide) on whole-body protein metabolism in healthy man","volume":"27","author":"Shalev","year":"1997","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI0215595","article-title":"Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons","volume":"110","author":"Yamamoto","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1280","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1523\/JNEUROSCI.5977-08.2009","article-title":"Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity","volume":"29","author":"Nogueiras","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1285","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1172\/JCI105685","article-title":"Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects","volume":"46","author":"Perley","year":"1967","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1290","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diabetes.48.5.1026","article-title":"Glucose-lowering and insulinsensitizing actions of exendin-4: studies in obese diabetic","volume":"48","author":"Young","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1295","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom","volume":"267","author":"Eng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1300","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.109.160531","article-title":"Pharmacological characterization of human incretin receptor missense variants","volume":"332","author":"Fortin","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1305","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2011.02.001","article-title":"Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation","volume":"13","author":"Hayes","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1310","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.110.166470","article-title":"Transferrin fusion technology: a novel approach to prolonging biological half-life ofinsulinotropic peptides","volume":"334","author":"Kim","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1315","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/oby.2000.38","article-title":"Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa\/fa) Zucker rats","volume":"8","author":"Al-Barazanji","year":"2000","journal-title":"Obes. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1320","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/oby.2011.342","article-title":"Glucagon-like peptide-1 regulation of carbohydrate intake is differentially affected byobesogenic diets","volume":"20","author":"Pritchett","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1325","doi-asserted-by":"crossref","first-page":"R1011","DOI":"10.1152\/ajpregu.00424.2010","article-title":"Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4","volume":"301","author":"Baraboi","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1330","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2010.05.017","article-title":"Glucagon-like peptide-1 protects NSC-34 motor neurons against glucosamine through Epac-mediated glucose uptake enhancement","volume":"479","author":"Lim","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1335","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/gut.38.6.916","article-title":"Attenuated GLP-1 secretion in obesity: cause or consequence?","volume":"38","author":"Ranganath","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1340","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1079\/BJN20041335","article-title":"Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects","volume":"93","author":"Adam","year":"2005","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1345","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1210\/jc.2005-0904","article-title":"Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects","volume":"91","author":"Mor\u00ednigo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1350","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/ijo.2008.157","article-title":"Postprandial changes in gut regulatory peptides in gastric bypass patients","volume":"32","author":"Holdstock","year":"2008","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1355","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/gut.44.1.81","article-title":"Glucagon-like peptide-1: a potent regulator of food intake in humans","volume":"44","author":"Gutzwiller","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1360","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ijo.0800818","article-title":"Energy intake and appetite is suppressed by glucagon-like peptide-1 (GLP-1) in obese men","volume":"3","author":"Naslund","year":"1999","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1365","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2010.05.002","article-title":"Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor","volume":"1344","author":"Washington","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1370","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/CS20110374","article-title":"Glucagon-like peptide 1 receptor activation reduces ischaemic brain damage followingstroke in Type 2 diabetic rats","volume":"122","author":"Darsalia","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1375","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/dc08-1797","article-title":"One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial","volume":"32","author":"Bunck","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1380","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajhp\/62.2.173","article-title":"Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus","volume":"62","author":"Kolterman","year":"2005","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1385","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2011.51","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia","volume":"31","author":"Teramoto","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1390","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/diabetes.51.5.1443","article-title":"Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4","volume":"51","author":"Tourrel","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1395","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1185\/030079908X253870","article-title":"Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3years","volume":"24","author":"Klonoff","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1400","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1463-1326.2010.01238.x","article-title":"Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis","volume":"12","author":"Fan","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1405","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.clinthera.2007.11.006","article-title":"Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial","volume":"29","author":"Barnett","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1410","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3233\/JAD-2010-1314","article-title":"GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease","volume":"19","author":"Li","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1415","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-2094-5-19","article-title":"Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease","volume":"5","author":"Harkavyi","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1425","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine induced peripheral sensory neuropathy","volume":"203","author":"Perry","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1430","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1435","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.102.037481","article-title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4","volume":"302","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1440","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jnr.10611","article-title":"Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron","volume":"72","author":"Perry","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1445","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clinthera.2005.02.008","article-title":"A randomized, open-label, crossover study examining the effect of injection site on bioavailability of exenatide (synthetic Exendin-4)","volume":"27","author":"Calara","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1450","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2010.59","article-title":"Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet","volume":"34","author":"Gault","year":"2010","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1455","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00125-006-0510-2","article-title":"A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study","volume":"50","author":"Nauck","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1460","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1465","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/diaclin.24.2.71","article-title":"Improving patient adherence","volume":"24","author":"Delamater","year":"2006","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1470","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","article-title":"The impact of medication regimen factors on adherence to chronic treatment: a review of the literature","volume":"31","author":"Ingersoll","year":"2008","journal-title":"J. Behav. Med."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1475","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mce.2008.11.018","article-title":"Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue","volume":"297","author":"Russell-Jones","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1480","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cercor\/1.1.103","article-title":"The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease","volume":"1","author":"Arnold","year":"1991","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1605","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2012.04.009","article-title":"Liraglutide protects against amyloid-\u03b2 protein induced impairment of spatial learning andmemory in rats","volume":"34","author":"Han","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1490","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1495","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/156720506777632817","article-title":"Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent","volume":"3","author":"Brinton","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1500","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1505","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1463-1326.2010.01259.x","article-title":"Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance","volume":"12","author":"Porter","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2013.01.008_bb1510","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1517\/13543784.2011.562191","article-title":"Lixisenatide for type 2 diabetes mellitus","volume":"20","author":"Christensen","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1610","article-title":"Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob\/ob mice","author":"Porter","year":"2012","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1520","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1525","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2013.01.008_bb1530","first-page":"1410","article-title":"Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans","volume":"45","author":"Vella","year":"2002","journal-title":"Diabetologia"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T16:19:14Z","timestamp":1714839554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":304,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0925443913000124"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.01.008","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}